FDA Warns of Possible Bacteria Contamination of Tattoo Inks

FRIDAY, May 9, 2025 (HealthDay News) -- Two tattoo inks have tested positive for harmful bacteria and the use of them could lead to serious infections, according to an alert from the U.S. Food and Drug Administration.The following products are affected: Sacred Tattoo Ink, Raven Black (CI# 77266; Lot#: RB0624, Best Before: June 28, 2027), and Sacred Tattoo Ink, Sunny Daze (CI# 21095; Lot#: SD1124, Best Before: Nov. 1, 2027).FDA testing revealed the inks were contaminated with bacteria such as Pseudomonas aeruginosa, which can cause infections when injected into the skin.These infections can cause red rashes, bumps, or lesions and may leave permanent scars if not treated correctly, according to an FDA news release."There is an increased risk of infection any time the skin barrier is broken," the FDA said.Symptoms of infection can sometimes be mistaken for an allergic reaction, which can cause a delay in getting the right treatment.The FDA discovered the contaminated inks during a routine survey of tattoo products. The agency relied on microbiological testing methods typically used for cosmetics.Tattoo artists and studios are urged to avoid using or selling these specific inks. Consumers are advised to ask their tattoo artist what inks are being used and to avoid the affected products.The FDA said it is working with manufacturers and sellers to remove these products from the market.Anyone who experiences a reaction after getting a tattoo should contact a health care provider and report the issue through the FDA SmartHub.More Information.Sign up for our weekly HealthDay newsletter

FDA Warns of Possible Bacteria Contamination of Tattoo Inks

Related Stories

Toddler Snacks Pulled From Costco, Target, Walmart And Other Stores Over Choking Danger

Summer’s Produce Outbreaks Expose Gaps In FDA Oversight Of Imported Food

New Drug Could Let Some Rectal Cancer Patients Skip Chemotherapy, Radiation And Surgery

Herpes ‘Remedies’ Sold On Amazon And Walmart Pose Public Health Risk, FDA Warns